1) To appreciate the technical requirements for lung SABR. 2) To appreciate the current outcomes for local control and survival. 3) To appreciate the challenges in response assessment. 4) To appreciate the toxicities associated with lung SABR.
There is clinical evidence to suggest that local aggressive therapy such as surgical resection may prolong survival and may even achieve a cure in selected patients with lung oligometastasis . Stereotactic ablative radiotherapy (SABR) has emerged as an alternative treatment option for lung oligometastases and promising results have been observed in multiple retrospective studies and single arm clinical trials. More research is needed to better define the role of SABR in the management of lung oligometastasis.
Lo, S,
SABR for Lung Oligometastases. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/13012323.html
